Drawing for B BIBO PHARMA

USPTO serial 97728542

B BIBO PHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
MAKSHOOD, AKEELA MOHAMED
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with B BIBO PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Antivirals; Vaccines; Allergy relief medication; Anti-cancer preparations; Anti-diabetic preparations; Biological tissue cultures for medical purposes; Cultures of microorganisms for medical or veterinary use; Dietetic foods adapted for medical purposes; Fertility enhancement preparations; Medicinal hair growth preparations; Nutritional supplements; Pituitary hormone preparations; Probiotic supplements; Protein dietary supplements; Protein supplements for animals; Stem cells for medical purposes; Vaccines for horses; Veterinary vaccines; Yeast dietary supplements; Yeast extracts for medical, veterinary or pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Yeast for pharmaceutical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2024WOAGWITHDRAWAL OF ATTORNEY GRANTED
Oct 17, 2024WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jul 29, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 7, 2023DOCKASSIGNED TO EXAMINER
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2023XAECEXAMINER'S AMENDMENT ENTERED
Sep 25, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 25, 2023GNEAEXAMINERS AMENDMENT E-MAILED
Sep 25, 2023CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 22, 2023DOCKASSIGNED TO EXAMINER
Jan 20, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 19, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 26, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance